Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory University Oct 1, 2020
Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites Sep 29, 2020
Additional Independent Research Further Supports Glucose Metabolism as Important COVID-19 Target Jul 29, 2020
Moleculin Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus Jul 21, 2020
